健脾养血祛风法调节AD的免疫屏障的研究进展

杨洋; 杨雪松; 叶建州; 李泓莹; 陈思璇

doi:10.12259/j.issn.2095-610X.S20210220

健脾养血祛风法调节AD的免疫屏障的研究进展

doi: 10.12259/j.issn.2095-610X.S20210220

云南中医药大学第一附属医院皮肤科，云南昆明　650021

基金项目: 国家自然科学基金资助项目（81660798）；云南省科技厅重点基金资助项目（2017FA047）；云南中医药大学第一附属医院中医药防治皮肤病省创新团队基金资助项目（2019HC001）

详细信息

作者简介:
杨洋（1992～），女，河南郸城人，在读硕士研究生，主要从事特应性皮炎、银屑病的中医防治研究工作

通讯作者:
叶建州，E-mail： kmyjz63@sina.com

中图分类号: R246.7
计量
- 文章访问数: 2939
- HTML全文浏览量: 1801
- PDF下载量: 19
- 被引次数: 0
出版历程
- 收稿日期: 2020-11-13
- 刊出日期: 2021-02-25

Progress on Regulating Immune Barrier of Atopic Dermatitis by Jianpi Yangxue Qufeng Decoction

Dept. of Dermatology，The 1st Affiliated Hospital of Yunnan University of Traditional Chinese Medicine，Kunming Yunnan 650021，China

摘要

摘要: 特应性皮炎（atopic dermatitis，AD）又名特应性湿疹、Besnier体质性痒疹或遗传过敏性湿疹，是一种以湿疹样皮损、剧烈瘙痒及本人或其家族中可见显著的“特应性”为临床特点的皮肤病。近年来，对AD发病机制的理论不断倾向于新的免疫屏障功能的异常，目前发现健脾养血祛风法用于治疗血虚风燥型AD具有确切的疗效，可有效消除皮损，减少复发率，调节特应性皮炎的免疫屏障功能，现就关于健脾养血祛风法调节AD的免疫屏障功能的机制进行综述。
- 特应性皮炎 /
- 健脾养血祛风法 /
- 免疫屏障功能
Abstract: Atopic dermatitis（AD）also known as atopic eczema, Besnier prurigo diathesique or hereditary allergic eczema, is a skin disease characterized by eczema-like skin lesions, severe itching and obvious "atopy" in oneself or his family. In recent years, the theory of AD pathogenesis tends to be abnormal in immune barrier function. At present, it has been found that the method of Jianpi Yangxue Qufeng Decoction has definite curative effect in treating AD with Xuexu Fengzao type, which can effectively control skin lesions, reduce recurrence rate and regulate the immune barrier function of AD. This article reviews the mechanism of regulating the immune barrier function of AD by the method of Jianpi Yangxue Qufeng Decoction.
- Atopic dermatitis /
- Jianpi yangxue qufeng decoction /
- Immune barrier function

HTML全文

参考文献(45)

[1]	Gandhi N A,Pirozzi G,Graham N M H. Commonality of the IL-4/IL-13 pathway in atopic diseases[J]. Expert Review of Clinical Immunology,2017,13(5):425-437. doi: 10.1080/1744666X.2017.1298443
[2]	王丽芬,叶建州,杨雪松. 健脾养血祛风汤治疗血虚风燥型特应性皮炎患者临床疗效及对患者皮肤屏障功能的影响[J]. 中国实验方剂学杂志,2018,24(13):178-182.
[3]	朱慧婷,尚宝令,李伯华,等. 健脾润肤汤对特应性皮炎脾虚证患者细胞因子的影响[J]. 西部中医药,2018,31(9):1-4. doi: 10.3969/j.issn.1004-6852.2018.09.001
[4]	Novak N,Koch S,Allam J P,et al. Dendritic cells:Bridging innate and adaptive immunity in atopic dermatitis[J]. J Allergy Clin Immunol,2010,125(1):50-59. doi: 10.1016/j.jaci.2009.11.019
[5]	Hvid M,Vestergaard C,Kemp K,et al. IL-25 in atopic dermatitis:a possible link between inflammation and skin barrier dysfunction[J]. Invest Dermatol,2011,131(1):150-157. doi: 10.1038/jid.2010.277
[6]	杨雪松,叶建州,罗光云,等. 健脾养血祛风方对树突状细胞 TLRs/MyD88/NF-kB 信号通路的干预机制[J]. 昆明医科大学学报,2019,40(11):13-20. doi: 10.3969/j.issn.1003-4706.2019.11.003
[7]	Sun,Lixiang,Wenjie Liu,Ling-juan Zhang. The role of toll-like receptors in skin host defense,psoriasis,and atopic dermatitis[J]. Journal of Immunology,2019,14(2019):1824624.
[8]	Yu Y,Lin D,Cai X,et al. Enhancement of chemokine mRNA expression by toll-like receptor 2 stimulation in human peripheral blood mononuclear cells of patients with atopic dermatitis[J]. BioMed Research International,2020,19:1497175.
[9]	白书仙,卫静,贺琪,等. 健脾养血汤对特异性皮炎小鼠模型中Toll样受体的表达影响及意义[J]. 江西中医药大学学报,2020,32(1):90-92.
[10]	Antiga E,Volpi W,Torchia D,et al. Effects of tacrolimus ointment on Toll-like receptors in atopic dermatitis[J]. Clinical and Experimental Dermatology,2011,36(3):235-241. doi: 10.1111/j.1365-2230.2010.03948.x
[11]	Nakamura N,Tamagawa-Mineoka R,Ueta M,et al. Stratum corneum toll-like receptor 3 expressions correlate with the severity of atopic dermatitis lesions[J]. Journal of Dermatological Science,2019,94(3):354-357. doi: 10.1016/j.jdermsci.2019.05.005
[12]	Liu Y J. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation[J]. J Allergy Clin Immunol,2007,120(2):238-244. doi: 10.1016/j.jaci.2007.06.004
[13]	Zimmermann M,Koreck A,Meyer N,et al. THF-like weak inducer of apoptosis(TWEAK)and TNF-α cooperate in the induction of keratinocyte apoptosis[J]. J Allergy Clin Immunol,2011,127(1):200-210. doi: 10.1016/j.jaci.2010.11.005
[14]	孙晓冬,游洋,刘岩,等. 当归饮子治疗特应性皮炎的疗效分析及对患者免疫功能调节作用研究[J]. 长春中医药大学学报,2018,36(6):1153-1156.
[15]	郑永平,陈高飞,张玲,等. 补脾祛风方对脾虚型特应性皮炎患者血清总免疫球蛋白、嗜酸性粒细胞的影响[J]. 国际中医中药杂志,2012,34(5):407-408. doi: 10.3760/cma.j.issn.1673-4246.2012.05.007
[16]	苏传丽,吴志洪. 红花逍遥片对血虚风燥型特应性皮炎患者免疫因子影响的研究[J]. 实用中西医结合临床,2015,15(10):10-13.
[17]	Sonkoly E,Janson P,Majuri M L,et al. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4[J]. J Allergy Clin Immunol,2010,126(3):581-589. e20.
[18]	Ma L,Xue H B,Wang F,et al. MicroRNA-155 may be involved in the pathogenesis of atopic dermatitis by modulating the differentiation and function of T helper type 17(Th17)cells[J]. Clin Exp Immunol,2015,181(1):142-149. doi: 10.1111/cei.12624
[19]	吴志洪,苏传丽,钟江,等. 不同证型特应性皮炎患者皮损microRNAs表达谱的研究[J]. 南京中医药大学学报,2017,33(1):14-18.
[20]	Paller A S,Kong H H,Seed P,et al. The microbiome in patients with atopic dermatitis[J]. J Allergy Clin Immunol,2019,143(1):26-35. doi: 10.1016/j.jaci.2018.11.015
[21]	Yockey L J,Demehri S,Turkoz M,et al. The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation[J]. Invest Dermatol,2013,133(12):2714-2721. doi: 10.1038/jid.2013.228
[22]	Bjerkan L,Schreurs O,Engen S A,et al. The short form of TSLP is constitutively translated in human keratinocytes and has characteristics of an antimicrobial peptide[J]. Mucosal Immunol,2015,8(1):49-56. doi: 10.1038/mi.2014.41
[23]	Kim H S,Yun J W,Shin T H,et al. Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-beta1 alleviate atopic dermatitis by reducing mast cell degranulation[J]. Stem Cells,2015,33(4):1254-1266. doi: 10.1002/stem.1913
[24]	Park H, Lee S, Yu Y, et al. TGF-β secreted by human umbilical cord blood-derived mesenchymal stem cells ameliorates atopic dermatitis by inhibiting secretion of TNF-α and IgE[J]. Stem Cells, 2020, 11. doi: 10.1002/stem.3183. Epub ahead of print. PMID: 32277785.
[25]	Yoshihara Y,Ishiuji Y,Yoshizaki A,et al. IL-10-Producing regulatory B cells are decreased in patients with atopic dermatitis[J]. J Invest Dermatol,2019,139(2):475-478. doi: 10.1016/j.jid.2018.08.016
[26]	Saulep-Easton D. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLLB cells[J]. Leukemia,2015,30(1):163-172.
[27]	Jee H M,Kim K W,Hong J Y,et al. Increased serum B cell-activating factor Level in children with atopic dermatitis[J]. Clin Exp Dermatol,2010,35(6):593-598.
[28]	Hayashi M,Yanaba K,Umezawa Y,et al. IL-10-producing regulatory B cells are decreased in patients with psoriasis[J]. J Dermatol Sci,2016,81(2):93-100. doi: 10.1016/j.jdermsci.2015.11.003
[29]	Gu Y,Li K,Sun J,et al. Characterization of CD19⁺CD24^hiCD38^hiB cells in chinese adult patients with atopic dermatitis[J]. European Academy of Dermatology and Venereology,2020,34(12):2863-2870. doi: 10.1111/jdv.16399
[30]	Silverberg J I. Atopic dermatitis treatment:Current state of the art and emerging therapies[J]. Allergy Asthma Proc,2017,38(4):243-249. doi: 10.2500/aap.2017.38.4054
[31]	Simpson E L, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis [ J]. N Engl J Med, 2016, 375（24）: 2335-2348.
[32]	Shah N,Alhusayen R,Walsh S,et al. Methotrexate in the treatment of moderate to severe atopic dermatitis:A retrospective study[J]. J Cutan Med Surg,2018,22(5):484-487. doi: 10.1177/1203475418781336
[33]	Udkoff J,Waldman A,Ahluwalia J,et al. Current and emerging topical therapies for atopic dermatitis[J]. Clin Dermatol,2017,35(4):375-382. doi: 10.1016/j.clindermatol.2017.03.010
[34]	秦万章. 血燥证理论在皮肤科中的应用[J]. 中国中西医结合皮肤性病学杂志,2014,13(1):1-6.
[35]	黄业坚,刘俊峰,陈达灿,等. 陈达灿教授治疗特应性皮炎经验浅谈[J]. 中国中西医结合皮肤性病学杂志,2010,9(3):165-166.
[36]	张斌,熊述清,杜泽敏,等. 国医大师禤国维治疗特应性皮炎临床经验探析[J]. 江苏中医药杂志,2019,51(2):17-20.
[37]	姚守恩,周渐云. 许铣治疗异位性皮炎经验[J]. 实用中医药杂志,2006,22(2):116. doi: 10.3969/j.issn.1004-2814.2006.02.056
[38]	郭静,肖敏,彭丽,等. 艾儒棣从脾胃论治小儿特应性皮炎经验[J]. 中华中医药杂志,2017,32(8):3534-3536.
[39]	李晨帅. 任勤教授辨治儿童特应性皮炎临床经验[J]. 中医儿科杂志,2019,15(4):21-23.
[40]	何丹,林青,王妍. 特应性皮炎的中医辨证及用药规律[J]. 云南中医学院学报,2009,32(4):66-67. doi: 10.3969/j.issn.1000-2723.2009.04.023
[41]	叶建州,杨雪松,李钦. 健脾养血祛风法对小鼠皮肤屏障功能影响的实验研究[J]. 云南中医中药杂志,2012,33(12):58-60. doi: 10.3969/j.issn.1007-2349.2012.12.034
[42]	杨雪松,叶建州,李钦. 健脾养血祛风法治疗特应性皮炎临床疗效及对皮肤屏障功能的影响[J]. 云南中医中药杂志,2009,32(3):5-7,12.
[43]	王丽芬,杨雪松,叶建州. 健脾养血祛风汤治疗血虚风燥型特应性皮炎的疗效及对患者血清LTB4、LTC4水平的影响[J]. 时珍国医国药,2018,29(3):641-643.
[44]	彭勇,李斌,王英杰,等. 健脾祛风方治疗脾虚型特应性皮炎临床疗效评价[J]. 中医药导报,2013,19(5):11-13. doi: 10.3969/j.issn.1672-951X.2013.05.005
[45]	陈保疆. 养血健脾润肤法治疗特应性皮炎临床疗效观察及对患者血清白细胞介素18的影响[J]. 中国中西医结合皮肤性病学杂志,2014,13(5):283-285. doi: 10.3969/j.issn.1672-0709.2014.05.004

相关文章(20)

[1]	汪鑫邦, 胡安, 赵喜鹏, 汪炎, 丁伟, 操礼鹏, 古禹, 许轲, 张云峰. Ommaya囊治疗脑出血并发急性期脑积水疗效及对血脑屏障功能的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241015
[2]	万鑫蕊, 王晓燕, 王霖, 马志强, 李才信, 许世涛, 唐兴蕊, 毛红艳. 非结核分枝杆菌感染者肝肾功能、免疫功能和耐药性分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231117
[3]	杨成林, 胡婕, 王静, 王敏华, 黄玲. Th17和Treg细胞与慢性光化性皮炎的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230511
[4]	杨童欣, 王光, 徐蕊, 苏思维, 方克伟, 刘建和, 李炯明. 抗菌肽LL-37对尿路上皮细胞跨膜屏障功能破坏的作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220806
[5]	赵树波, 李爱林, 梁武, 宁金梅. 丙酸氟替卡松鼻雾剂联合皮下免疫治疗变应性鼻炎, 昆明医科大学学报.
[6]	陈欣玥, 陈宗翰, 赵维佳. 地奈德乳膏联合复方多粘菌素B软膏治疗儿童中重度特应性皮炎, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20201228
[7]	於晓东, 龙江. 12外泌体对体外血脑屏障模型功能的影响, 昆明医科大学学报.
[8]	杨雪松, 叶建州, 罗光云, 李柏橙, 甘宁. 健脾养血祛风方对树突状细胞TLRs/MyD88/NF-kB信号通路的干预机制, 昆明医科大学学报.
[9]	王胜虎. 全自动酶联免疫分析仪与手工酶联免疫法的检测结果比较, 昆明医科大学学报.
[10]	雷东云. 慢性光化性皮炎169例临床回顾分析, 昆明医科大学学报.
[11]	陈宗劼. 他克莫司软膏治疗激素依赖性皮炎139例临床疗效观察, 昆明医科大学学报.
[12]	刘燕南. 喂养干预辅助治疗婴儿特应性皮炎临床观察, 昆明医科大学学报.
[13]	陈娟. 他克莫司软膏与糠酸莫米松乳膏治疗慢性光化性皮炎疗效观察, 昆明医科大学学报.
[14]	梁正菊. 龙血竭胶囊加紫草油治疗放射性皮炎的临床疗效观察, 昆明医科大学学报.
[15]	胡霄. HIV-1 Tat蛋白改变血脑屏障结构和功能的研究进展, 昆明医科大学学报.
[16]	郭峰. 甲状腺激素对大鼠急性肝衰竭肠粘膜屏障功能影响的实验研究, 昆明医科大学学报.
[17]	葛玉明. 甲状腺激素对大鼠急性肝衰竭肠粘膜屏障功能的保护作用, 昆明医科大学学报.
[18]	邓丹琪. 多形性日光疹和慢性光化性皮炎的光生物试验及光疗, 昆明医科大学学报.
[19]	朱兴宝. 轴突生长抑制因子DNA疫苗免疫促进脑缺血后神经功能恢复, 昆明医科大学学报.
[20]	张雁丽. 化合物LJZ对小鼠移植瘤生长和荷瘤小鼠免疫功能的影响, 昆明医科大学学报.